The quinolones market is projected to register a CAGR of 4% during the forecast period, up from US$ 46.7 Bn in 2021 to reach a valuation of US$ 72 Bn by 2032.
The quinolones market is anticipated to show promising growth prospects during the forecast period as a result of growing competition. New competitors are offering a variety of options at reasonable pricing to fulfil the demand for quinolones making them more accessible to customers in the global quinolones market.
A quinolone antibiotic is a broad-spectrum bactericide that has a bicyclic core structure with the chemical 4-quinolone. Quinolones are used to treat bacterial infections in both veterinary and human medicine, as well as in animal husbandry. Quinolones are classified into five distinct classes, one of which is antibiotics. Quinolones are effective against bacterial infections of the skin, stomach, lungs, sinuses, and urinary tract.
| Report Attribute | Details |
| Estimated Base Year Value (2021) | US$ 46.7 Billion |
| Expected Market Value (2022) | US$ 48.5 Billion |
| Anticipated Forecast Value (2032) | US$ 72 Billion |
| Projected Growth Rate (2022-2032) | 4% CAGR |
Sales of quinolones are expected to rise significantly. In addition to this, demand for quinolones is rising on account of US$ 56.8 Bn by 2026. Increasing demand for quinolones is also projected to contribute to the growth of the quinolones market share.
Quinolones can interfere with human DNA synthesis due to their ability to impede nucleic acid synthesis. Humans have the same fundamental nucleic acid contents as bacteria. Quinolone antibiotics are becoming more widely available. Manufacturers who are innovative in the pharmaceutical market are developing new antibiotics to increase the sales of quinolones. For example, by adding fluoride to the original quinolone antibiotic molecules, a new family of antibiotics was created.
Manufacturers in the quinolones market get a big platform from which to serve the whole demand for quinolones. The worldwide quinolones market is seeing increased competition. With growing competition, new competitors are offering a variety of options at reasonable pricing, fulfilling the demand for quinolones more accessible to customers.
Johnson & Johnson Services, Inc., Sanofi S.A., Bayer AG, Merck & Co, Inc., Allergan, Inc., Novartis AG, and LG Chem (LG Life Sciences) are some of the leading participants in the quinolones market.
Several quinolones are currently available for the treatment of animals worldwide, including poultry and fish. At the same time, it is also utilized as a disease preventative in many places, these properties of quinolones aid to drive the existing demand for quinolones market and also help to produce opportunities for good sales of quinolones to the manufacturers throughout the anticipated time.
Increased demand for quinolones due to their low price, which includes fewer side effects, good oral absorption, easier once- or twice-daily dosage, easier tissue penetration, and broad-spectrum activity against several pathogenic bacterial strains, helps to fuel current sales of quinolones and also creates an opportunity for the quinolones market.
Other factors driving the sales of quinolones include the rising prevalence of multidrug-resistant bacteria, which raises public health concerns and creates opportunities for medication producers. The European Medicines Agency's pharmacovigilance risk assessment committee has suggested restricting the sales of quinolones antibiotics by mouth, inhalation, or injection due to their long-lasting adverse effects.
There are certain rare side effects, such as impairing the muscles, bones, tendons, and nervous system. This constraint may limit the growth ofquinolones market share in the anticipated time while also lowering sales of quinolones in the present era. As a result, numerous producers are exiting the quinolones market, and the overall market size is shrinking.
Thus, producers may enhance sales of quinolones in pharmaceuticals via invention and development and minimize major adverse effects for customers. This innovation in the quinolones market of pharmaceuticals serves to pave the way for future opportunities and also helps to fulfill the pharmaceutical demand for quinolones.
The worldwide sales of quinolones may be split geographically into North America, Asia Pacific (APAC), Europe, Latin America, the Middle East and Africa, and the Rest of the World (RoW). Whereas North America and the Asia Pacific now maintain sizable demand for quinolones in the global quinolones market.
Whereas in Europe, numerous agencies conduct research and development on pharmaceutical products and their effects, they discovered the impact on demand for quinolones, which are not beneficial. As a result, the quinolones market in the European area is unlikely to increase at a profitable rate assuring moderate sales of quinolones.
Johnson & Johnson Services, Inc., Sanofi S.A., Bayer AG, Merck & Co, Inc., Allergan, Inc., Novartis AG and LG Chem (LG Life Sciences) are some of the leading participants in the quinolones market.
| Report Attribute | Details |
| Growth rate | CAGR of 4% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 - 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Type, form, region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled |
|
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail of customized purchase options to meet your exact research needs. |
By Type:
By Form:
By Region:
The quinolones market is predicted to register a CAGR of 4% during the forecast period.
Key players holding substantial quinolones market share include Johnson & Johnson Services, Inc., Sanofi S.A., Bayer AG, Merck & Co, Inc., Allergan, Inc., Novartis AG and many more.
As per the analysis, the quinolones market share is likely to be US$ 56.8 Bn by 2026.
Other factors driving the sales of quinolones include the rising prevalence of multidrug-resistant bacteria, which raises public health concerns and creates opportunities for medication producers.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Fluoroquinolones ELISA Kit Market Size and Share Forecast Outlook 2025 to 2035
Quinolones Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
